<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11329345</article-id><article-id pub-id-type="pmcid-ver">PMC11329345.1</article-id><article-id pub-id-type="pmcaid">11329345</article-id><article-id pub-id-type="pmcaiid">11329345</article-id><article-id pub-id-type="manuscript-id">NIHMS2009096</article-id><article-id pub-id-type="pmid">38968835</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2024.111379</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2009096</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2009096</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Trends in Recurrent Overdose and Treatment Initiation Following Emergency Department Visits for Opioid Overdose between 2016 and 2021</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Yangchen</surname><given-names initials="T">Tenzin</given-names></name><degrees>MA</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names initials="M">McClaren</given-names></name><degrees>MPH</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baird</surname><given-names initials="J">Janette</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hallowell</surname><given-names initials="BD">Benjamin D.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Daly</surname><given-names initials="MM">Mackenzie M.</given-names></name><degrees>MPA</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Berk</surname><given-names initials="J">Justin</given-names></name><degrees>MD, MPH, MBA</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gaither</surname><given-names initials="R">Rachel</given-names></name><degrees>BS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wightman</surname><given-names initials="RS">Rachel S.</given-names></name><degrees>MD, FACMT</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Beaudoin</surname><given-names initials="FL">Francesca L.</given-names></name><degrees>MD, PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chambers</surname><given-names initials="LC">Laura C.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA</aff><aff id="A2"><label>2</label>Substance Use Epidemiology Program, Rhode Island Department of Health, Providence, Rhode Island, USA</aff><aff id="A3"><label>3</label>Department of Emergency Medicine, Brown University, Providence, Rhode Island, USA</aff><aff id="A4"><label>4</label>Research, Data Evaluation, and Compliance Unit, Rhode Island Department of Behavioral Healthcare, Developmental Disabilities, and Hospitals, Providence, Rhode Island, USA</aff><aff id="A5"><label>5</label>Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><underline>Contributors</underline>: Authors contributed to the manuscript (MS) in the following manner. Study concept: Baird, Hallowell, Beaudoin, Chambers. Study design: Baird, Hallowell, Beaudoin, Chambers. Data analysis: Rodriguez, Hallowell. Interpretation of results: Yangchen, Rodriguez, Baird, Hallowell, Daly, Berk, Gaither, Wightman, Beaudoin, Chambers. Initial drafting of the MS: Yangchen, Chambers. Critical editing and revision of the MS: Yangchen, Rodriguez, Baird, Hallowell, Daly, Berk, Gaither, Wightman, Beaudoin, Chambers.</p></fn><corresp id="CR1"><underline>Corresponding author</underline>: Laura C. Chambers, Brown University Department of Epidemiology, Box G-S121-2, 121 South Main Street, Providence, Rhode Island, 02912; <email>laura_chambers@brown.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P28"><bold>Conflicts of interest:</bold> All authors declare that they have no conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>24</day><month>6</month><year>2024</year></pub-date><volume>262</volume><issue-id pub-id-type="pmc-issue-id">468975</issue-id><fpage>111379</fpage><lpage>111379</lpage><pub-history><event event-type="nihms-submitted"><date><day>27</day><month>07</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-28 22:25:13.707"><day>28</day><month>08</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2009096.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P2">Overdose remains a pressing public health concern in the United States, particularly with the emergence of fentanyl and other potent synthetic opioids in the drug supply. We evaluated trends in recurrent overdose and opioid use disorder (OUD) treatment initiation following emergency department (ED) visits for opioid overdose to inform response efforts.</p></sec><sec id="S2"><title>Methods:</title><p id="P3">This retrospective cohort study used electronic health record and statewide administrative data from Rhode Island residents who visited EDs for opioid overdose between July 1, 2016, and June 30, 2021, a period with fentanyl predominance in the local drug supply. The primary outcome was recurrent overdose in the 365 days following the initial ED visit. OUD treatment initiation within 180 days following the initial ED visit was considered as a secondary outcome. Trends in study outcomes were summarized by year of the initial ED visit.</p></sec><sec id="S3"><title>Results:</title><p id="P4">Among 1,745 patients attending EDs for opioid overdose, 20% (n=352) experienced a recurrent overdose within 365 days, and this percentage was similar by year (p=0.12). Among patients who experienced any recurrent overdose, the median time to first recurrent overdose was 88 days (interquartile range=23&#8211;208), with 85% (n=299/352) being non-fatal. Among patients not engaged in OUD treatment at their initial ED visit, 33% (n=448/1,370) initiated treatment within 180 days; this was similar by year (p=0.98).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P5">Following ED visits for opioid overdose in Rhode Island from 2016&#8211;2021, the one-year risk of recurrent overdose and six-month treatment initiation rate remained stable over time. Innovative prevention strategies and improved treatment access are needed.</p></sec></abstract><kwd-group><kwd>overdose</kwd><kwd>opioid overdose</kwd><kwd>opioid use disorder</kwd><kwd>addiction treatment</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>